Clinical trial

Vortioxetine in Patients With Depression and Early Dementia

NCT04294654

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-28

PhasePHASE4

Study timeline

Study start (actual)2020-02-28Date precision: day

Registry last updated2022-08-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Dementiaunresolved

Interventions

VortioxetineDRUG · verified · RxNorm: vortioxetine

Sponsors & collaborators

H. Lundbeck A/Slead sponsor

ICON plccollaborator

Mapped research locations

SeoulSouth Korea2 BarcelonaSpain1 BialystokPoland1 LublinPoland1 BydgoszczPoland1 KatowicePoland1 RomeItaly1 TallinnEstonia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04294654 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.